SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-19-008728
Filing Date
2019-03-21
Accepted
2019-03-21 08:30:20
Documents
7
Period of Report
2019-05-02
Effectiveness Date
2019-03-21

Document Format Files

Seq Description Document Type Size
1 DEF 14A evok-def14a_20181231.htm DEF 14A 873195
2 GRAPHIC guvqfq2txkba000006.jpg GRAPHIC 55773
3 GRAPHIC guvqfq2txkba000001.jpg GRAPHIC 4419
4 GRAPHIC guvqfq2txkba000004.jpg GRAPHIC 2754
5 GRAPHIC guvqfq2txkba000005.jpg GRAPHIC 69286
6 GRAPHIC guvqfq2txkba000002.jpg GRAPHIC 2530
7 GRAPHIC guvqfq2txkba000003.jpg GRAPHIC 4489
  Complete submission text file 0001564590-19-008728.txt   1066934
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36075 | Film No.: 19695952
SIC: 2834 Pharmaceutical Preparations